Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CervoMed logo — Medicines for the Brain.

CervoMed

Medicines for the Brain.

Founded 2023 United States Boston, United States 20 employees Post-IPO Debt Total: $149.40M Health Care, Pharmaceutical

General Information

Company Name CervoMed
Founded Year 2023
Location United States Boston, United States
Employees 20
Industries Health Care, Pharmaceutical
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with CervoMed. To contact CervoMed, visit cervomed.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About CervoMed

CervoMed is a public, Boston, MA-based company that focuses on advancing CNS-focused therapeutics to benefit patients with neurodegenerative diseases. The company was originally launched in 2014 as EIP Pharma, Inc, by R&D executives from the pharmaceutical and biotech industry.

In August, 2023, EIP Pharma merged with Diffusion Pharmaceuticals, retaining EIP’s development pipeline, but changing their name to CervoMed (CRVO).

For more information about the company and updates, please visit www.cervomed.com/ or follow them on Twitter at @Cervo_Med.

Overall, CervoMed's focus on CNS therapeutics and its recent merger with Diffusion Pharmaceuticals position it as an innovative player in the neurodegenerative disease treatment space. With a strong leadership team and promising pipeline, CervoMed presents an intriguing investment opportunity for venture capitalists looking to support advancements in neuropharmacology.

Taxonomy: Biopharmaceuticals, Neurodegenerative Diseases, CNS Therapeutics, R&D, Pharmaceutical Industry, Biotech Industry, Mergers and Acquisitions, Public Companies, Boston, Medical Research, Drug Development, Clinical Trials, Healthcare Innovations

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $149.40M 4
RA Capital Management Soleus Capital Special Situations Funds
RA Capital Management, Soleus Capital +2
28 Mar 2024

CervoMed Alternatives & Competitors

CervoMed vs
Julius Clinical
Julius Clinical The Netherlands

Julius Clinical manages global clinical drug trials that will have a major impact on medicine and ma...

Private Equity
176 employees
Health Care, Pharmaceutical
CervoMed vs
Engrail Therapeutics
Engrail Therapeutics United States

Transforming the lives of patients with life-limiting diseases of the nervous system

Series B
34 employees
Health Care, Life Sciences
CervoMed vs
Pharmasset, Inc.
Pharmasset, Inc.

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and comme...

Post-IPO Equity
11 employees
Biotechnology, Health Care

FAQ About CervoMed

Medicines for the Brain.
CervoMed was founded in 2023.
CervoMed is headquartered in Boston, United States.
CervoMed operates in Health Care and Pharmaceutical. Its work centres on Biopharmaceuticals, Neurodegenerative Diseases, CNS Therapeutics and R&D.
CervoMed has approximately 20 employees.
CervoMed has completed 1 funding round, raising a total of $149.40M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to CervoMed include Julius Clinical, Engrail Therapeutics, Pharmasset, Inc., Alphyn Biologics, Inc., ClinChoice昆翎. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CervoMed and Julius Clinical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CervoMed, https://bouncewatch.com/company/cervomed, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes